Julphar is the largest generic pharmaceutical manufacturer in MENA. For over thirty years, we have been providing high quality, affordable medicines to families across the region. We operate thirteen internationally accredited facilities in the UAE and others located in Ethiopia, Bangladesh, and KSA. We maintain a large and diverse range of medicines targeting major therapeutic segments, inclusive of biotechnology. Our strong network ensures distribution to over 40 countries worldwide... Read more

Press Releases & Events


From one standalone facility in Ras Al Khaimah in 1980, Julphar operates today fifteen internationally certified manufacturing facilities globally.

Thirteen of our facilities are based in the UAE and cover production areas including tablets, syrups, suspensions and injectable products.

View all UAE Plants

As part of our ongoing international expansion strategy, we have recently launched manufacturing facilities in Ethiopia and in Bangladesh.

We will continue to focus on expanding our presence in the market with the launch of our Saudi Arabia facility, expected to begin its operations in 2017.

View all International Plants

At Julphar, quality always comes first and responsibility helps us successfully integrate social, environmental and economic factors into our practices at all levels of the organisation.

As for quality – our main objective is to ensure our patient's safety by producing high quality products through our word-class facilities... read more

As for responsibility – we partner with local and global companies to make a positive impact across all healthcare sectors... read more